Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 29, 2023Frontiers in ImmunologyOpen Access

A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

QRQianhe RenPZPengpeng ZhangXZXiao Zhang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ren et al. (2023) studied this question.

synapsesocial.com/papers/69dfec284fb243fc8e59225ahttps://doi.org/10.3389/fimmu.2023.1199040
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Analysis of genomics and immune infiltration patterns of epithelial-mesenchymal transition related to metastatic breast cancer to bone2020 · 43 citations
  2. 2Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment2020 · 483 citations
  3. 3Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma2021 · 60 citations
  4. 4Mitochondrial Sirtuin-3 (SIRT3) Prevents Doxorubicin-Induced Dilated Cardiomyopathy by Modulating Protein Acetylation and Oxidative Stress2022 · 81 citations
  5. 5Cancer-associated fibroblasts: An emerging target against esophageal squamous cell carcinoma2022 · 51 citations